Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Cytotoxic T cell (with granules)
[{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c1fbd2ded00211ea48b/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c1fbd2ded00211ea48b/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c1fbd2ded00211ea48a/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c1fbd2ded00211ea48a/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4bd/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4bd/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4bc/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4bc/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4bb/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4bb/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4ba/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4ba/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b9/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b9/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b8/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b8/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b7/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b7/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b6/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b6/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b5/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b5/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b4/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b4/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b3/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b3/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b2/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b2/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b1/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b1/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4b0/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4b0/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4af/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4af/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4ae/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4ae/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4ad/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4ad/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4ac/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4ac/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4ab/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4ab/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4aa/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4aa/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a9/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a9/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a8/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a8/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a7/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a7/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a6/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a6/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a5/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a5/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a4/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a4/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a3/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a3/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a2/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a2/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a1/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a1/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea4a0/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea4a0/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49f/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49f/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49e/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49e/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49d/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49d/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49c/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49c/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49b/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49b/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea49a/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea49a/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea499/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea499/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea498/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea498/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea497/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea497/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea496/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea496/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea495/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea495/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea494/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea494/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea493/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea493/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea492/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea492/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea491/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea491/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea490/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea490/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea48f/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea48f/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea48e/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea48e/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea48d/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea48d/63d94827bd2ded00211ea43d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c30bd2ded00211ea48c/63d94827bd2ded00211ea43d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c30bd2ded00211ea48c/63d94827bd2ded00211ea43d.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
cytotoxic,CTL,T cell,T-cell,tcell,granules,Tc,cytotoxic T lymphocyte,T lymphocyte,T-killer cell,killer cell,killer T cell,cytolytic T cell,CD8+ T-cell,CD8,t cell activation,activated,lymphocyte,white blood cell,WBC,killer cell,killer t cell,immune cell,immune system,immune response,immunity,immunology,adaptive immune system,cancer,cancer treatment,foreign cells,infection,viral infection,antigen recognition,differentiated,target cell,pathogen destruction,cytotoxic granules,apoptosis,proj-icon-suggestions-22q4,proj-icon-suggestions-22q4-pathology,cytotoxic,CTL,t cell
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
